Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 8, 2026Medical Journal of BabylonOpen Access

Correlation of Interleukin-17A and Beta-2-Microglobulin in Early Diagnosis of Patients with Hypertension Related Chronic Kidney Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

ZAZahraa Rady Jabor AljotharyIAIsraa Saeed Abbass

Discussion

Loading...

Member takes

Overview

Randomized trial evaluates IL-17A and β2-MG as inflammatory markers for CKD in hypertensive individuals, suggesting new diagnostic approaches.

Key Points

  • The aim is to evaluate IL-17A and β2-MG as inflammation markers in hypertensive CKD patients and their predictive capability for CKD.
  • 100 participants including 35 CKD patients with hypertension, 35 without hypertension, and 30 controls
  • Serum levels of IL-17A and β2-MG measured using enzyme-linked immune sorbent assay
  • Evaluation conducted across a diverse age range from 20 to 70 years
  • Significant differences in IL-17A and β2-MG concentrations in hypertensive CKD patients compared to controls
  • Markers indicate potential for earlier diagnosis of CKD than routine tests
  • Findings support IL-17A and β2-MG as key inflammation markers in hypertensive patients

Cite This Study

Aljothary et al. (2026) studied this question.

synapsesocial.com/papers/69fd7e00bfa21ec5bbf06418https://doi.org/10.4103/mjbl.mjbl_1600_23
View Full Paper
Ask AI
Bookmark
Share